Hims & Hers shares rose nearly 6% on the news. Leerink has estimated a $2.2 billion telehealth market if all seven reviewed peptides get cleared.
Recap by typeshit. Full story at Asianet Newsable.
A man says Mounjaro and Trulicity caused his gastroparesis, and the clip walks through who must warn patients about side effects under Indiana law.
Alicia Butterfield claims Anthem denied her Zepbound once the drug got her below morbid obesity. A Los Angeles judge stayed her case pending arbitration.
STAT
Members of Congress from both parties want the FDA to stop imports of copycat versions of Eli Lilly's experimental obesity drug, which is still in trials.
The lawsuits center on sudden vision loss, a possible link researchers have been studying in weight loss drugs for several years.
35:20
Manuel Enrique runs a second 50 day stretch on peptides and reports how it went. These are personal claims, not established results.
In a NOLA.com guest column, Vidrine asks Sen. Bill Cassidy and FDA nominee Heidi Overton to tackle social media algorithms pushing unregulated injectables to minors.
Loading…